RNA interference dynamics in juvenile Fasciola hepatica are altered during in vitro growth and development by McCusker, Paul et al.
International Journal for Parasitology: Drugs and Drug Resistance 14 (2020) 46–55
Available online 19 August 2020
2211-3207/© 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
RNA interference dynamics in juvenile Fasciola hepatica are altered during 
in vitro growth and development 
Paul McCusker a,*, Wasim Hussain a, Paul McVeigh a, Erin McCammick a, Nathan G. Clarke a, 
Emily Robb a, Fiona M. McKay a, Peter M. Brophy b, David J. Timson c, Angela Mousley a, 
Nikki J. Marks a, Aaron G. Maule a 
a Microbe and Pathogen Biology, Institute for Global Food Security, School of Biological Sciences, Queen’s University Belfast, Belfast, UK 
b Institute of Biological, Environmental & Rural Sciences, Aberystwyth University, Aberystwyth, UK 
c School of Pharmacy & Biomolecular Sciences, University of Brighton, Brighton, UK   
A R T I C L E  I N F O   
Keywords: 
Fasciola 
Liver fluke 
RNAi 
Argonaute 
Calmodulin 
σGST 
A B S T R A C T   
For over a decade RNA interference (RNAi) has been an important molecular tool for functional genomics studies 
in parasitic flatworms. Despite this, our understanding of RNAi dynamics in many flatworm parasites, such as the 
temperate liver fluke (Fasciola hepatica), remains rudimentary. The ability to maintain developing juvenile fluke 
in vitro provides the opportunity to perform functional studies during development of the key pathogenic life 
stage. Here, we investigate the RNAi competence of developing juvenile liver fluke. Firstly, all life stages 
examined possess, and express, core candidate RNAi effectors encouraging the hypothesis that all life stages of 
F. hepatica are RNAi competent. RNAi effector analyses supported growing evidence that parasitic flatworms 
have evolved a separate clade of RNAi effectors with unknown function. Secondly, we assessed the impact of 
growth/development during in vitro culture on RNAi in F. hepatica juveniles and found that during the first week 
post-excystment liver fluke juveniles exhibit quantitatively lower RNAi mediated transcript knockdown when 
maintained in growth inducing media. This did not appear to occur in older in vitro juveniles, suggesting that 
rapidly shifting transcript dynamics over the first week following excystment alters RNAi efficacy after a single 
24 h exposure to double stranded (ds)RNA. Finally, RNAi efficiency was found to be improved through use of a 
repeated dsRNA exposure methodology that has facilitated silencing of genes in a range of tissues, thereby 
increasing the utility of RNAi as a functional genomics tool in F. hepatica.   
1. Introduction 
Fasciolosis, caused by liver fluke of the genus Fasciola, is responsible 
for considerable global agri-food sector losses (de Waal et al., 2007; Gray 
et al., 2008; Adrien et al., 2013; Khoramian et al., 2014) and, is recog-
nised as a neglected tropical disease by the World Health Organisation 
(WHO, 2015). Treatment for Fasciola infection relies on a small cohort of 
anthelmintics, although triclabendazole remains the current drug of 
choice due to its efficacy against most life stages in the mammalian host 
(Kelley et al., 2016). However, field resistance to triclabendazole was 
first reported in the mid-1990s (Overend and Bowen, 1995), and since 
then resistance cases have been reported worldwide (Kelley et al., 2016). 
Due to increasing resistance to triclabendazole and other flukicides 
(Novobilský and Hoglund, 2015) it is critical that either (i) the current 
drug cohort is improved, or (ii) novel drug/vaccine targets are identified 
and utilized to drive the discovery/development of new flukicides 
and/or vaccines. 
RNA interference (RNAi) is an amenable functional genomics tool 
that could prove pivotal in the discovery and validation of new flukicide 
and vaccine targets. Since its discovery (Fire et al., 1998), RNAi has 
facilitated reverse genetic screens in many parasitic helminths. Although 
there has been limited success with RNAi in animal parasitic nematodes 
(Viney and Thompson, 2008), RNAi has been successfully performed in 
a range of parasitic platyhelminths, such as Schistosoma, Fasciola, Mon-
iezia, Echinococcus, Opisthorchis, Hymenolepis and Clonorchis (Boyle et al., 
2003; Skelly et al., 2003; McGonigle et al., 2008; Pierson et al., 2010; 
Spiliotis et al., 2010; Sripa et al., 2011; Pouchkina-Stantcheva et al., 
2013; Wang et al., 2014). RNAi in schistosomes has resulted in a variety 
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of quantifiable phenotypes, informing the function and roles of many 
genes in this important pathogen. RNAi-based therapies have also been 
touted, although only one study demonstrated a modest reduction in 
infection following the injection of schistosome-targeting dsRNA into 
schistosome-infected mice (Pereira et al., 2008). 
Five studies on in vitro RNAi in F. hepatica juveniles have been pub-
lished (McGonigle et al., 2008; Rinaldi et al., 2008; Dell’Oca et al., 2014; 
McVeigh et al., 2014; McCammick et al., 2016). The cathepsin silencing 
reported by McGonigle et al. (2008) described reduced motility and 
aberrant migration through the intestinal wall whilst McCammick et al. 
(2016) reported a reduction in juvenile fluke growth and hyperactivity 
following the knockdown of calmodulin genes. Silencing of the exoge-
nous gene firefly luciferase resulted in a reduction in luciferase activity 
in newly excysted juveniles (NEJs) (Rinaldi et al., 2008) and various 
other genes have been silenced without any phenotypes being reported 
(Dell’Oca et al., 2014; McVeigh et al., 2014). To date, there have been no 
reports of serious morphological damage or lethality following RNAi 
studies in juvenile F. hepatica and it is unclear if this is simply due to the 
gene complement silenced thus far, is due to the in vitro culture condi-
tions or to RNAi pathway dynamics in early stage F. hepatica. 
In an effort to better understand the biology underpinning RNAi in 
liver fluke, we exploited available genomic/transcriptomic datasets for 
fluke to build a better understanding of the panel of RNAi effectors 
employed by these worms. Previous studies on the RNAi dynamics of 
schistosomes and Fasciola have focused on optimizing the delivery of 
dsRNA/siRNA to improve RNAi penetrance and persistence (Ndegwa 
et al., 2007; Stefanic et al., 2010; Dell’Oca et al., 2014; McVeigh et al., 
2014), but this study focuses on the impacts of growth/development on 
RNAi effectiveness. The latter is possible because we recently developed 
an in vitro maintenance and growth platform (McCusker et al., 2016) 
that allows the sustained maintenance of growing juvenile fluke. This 
platform enables the examination of RNAi responses in juvenile worms 
across early-stages of development in the mammalian host and over 
sustained timeframes, allowing us to explore the biology of growing 
fluke and to optimize RNAi-based functional genomics. 
2. Methods 
2.1. RNAi effector identification 
Protein sequences of RNAi/miRNA pathway effectors from 21 spe-
cies, both invertebrates and vertebrates, were recovered from www.wor 
mbase.org, parasite.wormbase.org, www.ncbi.nlm.nih.gov/protein, 
www.genedb.org and Dalzell et al. (2011) (Supplementary File 1). 
Family groups of RNAi effectors were aligned using Clustal Omega 
(www.ebi.ac.uk/Tools/msa/clustalo/) and converted to Stockholm 
format. Gblocks (molevol.cmima.csic.es/castresana/Gblocks_server. 
html) was used to identify conserved regions, which were then used to 
assemble query sequences on HMMER software (www.hmmer.org/). 
Query sequences were used to examine a F. hepatica genome predicted 
protein dataset (Cwiklinski et al., 2015), via a Hidden Markov Model 
(HMM) approach. There were 103 individual hits identified that were 
used in BLASTp searches against non-redundant databases to confirm 
sequence identity with conserved regions identified through Interpro 
(www.ebi.ac.uk/interpro/search/sequence-search). Note that initial 
RNAi effector protein identification and primer design was performed 
on sequences from an older genome assembly. An updated assembly was 
released whilst this manuscript was being prepared. We have used our 
original results to identify the most recent accession numbers (found on 
http://parasite.wormbase.org) using BLASTp searches. 
Protein model prediction was performed using Protein Homology/ 
analogY Recognition Engine V 2.0 (Kelley et al., 2015). Putative effec-
tors were aligned with Homo sapiens, Drosophila melanogaster, Caeno-
rhabditis elegans, Schistosoma mansoni and Schistosoma japonicum 
orthologues using MUSCLE (www.ebi.ac.uk/Tools/msa/muscle/), and 
visualised in Jalview (Waterhouse et al., 2009). Maximum-likelihood 
trees were constructed in MEGA7 (www.megasoftware.net/) by per-
forming 1000 bootstrap replications. 
2.2. Excystment and culture 
UK isolate F. hepatica eggs and metacercariae (from University of 
Liverpool, UK and Queen’s University Belfast, UK) were used for 
expression analyses, whilst F. hepatica Italian isolate metacercariae 
(Ridgeway Research, UK) and North-Western USA metacercariae 
(Baldwin Aquatics, USA) were used in RNAi trials (these isolates did not 
differ in RNAi susceptibility and are both reported to be susceptible to 
triclabendazole). Outer cyst walls were removed through mechanical 
separation of outer walls with a scalpel prior to incubation in 10% thin 
bleach at RT (5 min). Metacercariae were rinsed in dH2O five times 
before excystments were carried out as described in McVeigh et al. 
(2014). Newly excysted juveniles (NEJs; excysted within 4 h), were 
transferred to RPMI (RPMI 1640 (ThermoFisher Scientific) with Anti-
biotic/Antimycotic Solution x100 (Sigma-Aldrich) at 1:100). Worms for 
culture (referred to as juveniles) were placed in 96-well round bottom 
plates containing either RPMI or CS50 (50% chicken serum (Sigma-Al-
drich) in RPMI). 
2.3. Adult F. hepatica recovery 
Adult F. hepatica were recovered from condemned sheep livers at a 
local abattoir (ABP Meats, Lurgan, Northern Ireland), and transported to 
the laboratory in 15 mM NaCl (37 C). Fluke were maintained at 37 C in 
15 mM NaCl (replaced every 30 min) for around 1.5 h to encourage the 
regurgitation of gut contents. 
2.4. RNAi effector expression 
Eggs (1000/replicate), cysts (100/replicate), NEJs (100/replicate), 
two-week-old juveniles (20/replicate) and adults (1/replicate) were 
snap frozen in liquid nitrogen before lysis and extraction using the 
Dynabeads mRNA DIRECT Kit (ThermoFisher Scientific). Eluted mRNA 
samples were treated with TURBO DNase (ThermoFisher Scientific) 
prior to cDNA synthesis (High Capacity mRNA to cDNA Kit (Thermo-
Fisher Scientific)). 
Primers (Metabion International AG; Supplementary Table 1) were 
designed using Primer3Plus (Untergasser et al., 2007). End-point PCRs 
were used to confirm expression of RNAi effectors identified through 
HMM profiling in eggs, cysts, NEJs, two-week-old juveniles grown in 
CS50 and adults using the FastStart™ Taq DNA Polymerase, dNTPack 
(Sigma-Aldrich) with 0.4 μM of each primer, and 1 μl 1:1 diluted cDNA. 
PCR products were size confirmed on a 0.1% agarose gel and then 
sequence confirmed (Eurofins Scientific) after PCR clean up (ChargeS-
witch PCR Clean-Up Kit (ThermoFisher Scientific)). 
2.5. RNAi effector qPCR 
RNAi effector expression was compared between worms maintained 
in RPMI and CS50 by extracting mRNA from 20 worms/replicate after 
one week as described above. RNA concentrations were normalised 
using the Qubit® RNA High Sensitivity Assay Kit (ThermoFisher Sci-
entific) prior to reverse transcription (as above). qPCRs were run using 2 
μl cDNA (diluted 1:1) in a 10 μl reaction with 5 μl SensiFAST SBYR No- 
ROX Kit (Bioline) and 0.1 μM of each primer. ΔCt values were obtained 
using half of the Pfaffl equation (Pfaffl, 2001) with values transformed, 
via log2, to normalise expression. 
2.6. Juvenile RNAi 
Double stranded RNAs (dsRNA) specific to bacterial neomycin 
(bacterial neomycin phosphotransferase, U55762), F. hepatica σ-gluta-
thione-S-transferase (fhσgst, DQ974116), and F. hepatica calmodulin 2 
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(fhcam2, AM412547) were generated using the T7 RiboMAX™ Express 
RNAi System (Promega) with primers listed in Supplementary Table 2. 
Juveniles were excysted, as described above, and transferred into 96- 
well round bottom plates (at least three groups of 20 juveniles/repli-
cate were used for each experimental condition). RNAi trials were run 
over a period of three days to four weeks with various treatment regi-
mens. Juveniles grown in CS50 were washed three times in 200 μl prior 
to dsRNA treatment. At the conclusion of trials juveniles were snap 
frozen prior to mRNA extraction and reverse transcription, as described 
above. Transcript abundance was measured via qPCR as described above 
(except with 0.2 μM of each primer) with glyceraldehyde 3-phosphate 
dehydrogenase (fhgapdh, AY005475) used as a reference gene. Primers 
listed in Supplementary Table 2. ΔΔCt values were calculated using the 
Pfaffl equation, where untreated groups provided control values and 
dsRNA treated groups (both control dsRNA and target dsRNAs) provided 
experimental values, before conversion to percentage expression. 
Protein knockdown was assessed via western blot as described in 
McVeigh et al. (2014). Samples were normalised to 2 μg/μl in radio-
immunoprecipitation assay (RIPA) buffer using the Qubit® Protein 
Assay Kit (ThermoFisher Scientific) prior to processing as described in 
McVeigh et al. (2014) – primary and secondary antisera were as used in 
McVeigh et al. (2014) and McCammick et al. (2016). Membranes were 
developed for ~30 s before washing thoroughly in distilled water. 
Membranes were dried and scanned to quantify band densities in ImageJ 
(http://rsbweb.nih.gov/ij/). Band densities were normalised to in-
tensity of control band (FhCaM2 or FhσGST) to allow for relative 
quantitation. Untreated samples were considered to exhibit mean 
normal protein expression (100%) to allow control and target dsRNA 
samples to be expressed as percentages relative to the untreated worms. 
2.7. Statistical analyses 
T-tests and ANOVAs were used to test for significant differences 
between treatment groups. Graphs were created, and statistical tests 
carried out using GraphPad Prism 8 for Windows (GraphPad Software, 
La Jolla California USA, www.graphpad.com). 
3. Results 
3.1. RNAi effector identification and expression 
Of the 103 genes identified in the HMM screen, 27 were putative 
RNAi/miRNA pathway effectors of F. hepatica. These 27 genes/proteins 
comprise all of the core machinery believed to be necessary for a 
Fig. 1. The RNA interference (RNAi)/micro (mi)RNA pathway effectors of Fasciola hepatica. A – Summary of the putative RNAi/miRNA pathway in F. hepatica 
where double stranded (ds)RNA enters cells via SID-1 (1). Both dsRNAs and primary (pri)-miRNAs are processed by the dicer complex into short interfering (si)RNA 
or miRNA (2), which are then incorporated into the RNA-induced silencing complex (RISC) (3) and serve as guide RNAs to target complimentary mRNA for 
degradation (4). siRNAs and miRNAs may be trafficked into the nucleus (5). In the nucleus the Drosha complex processes pri-miRNAs into pre-miRNAs (6) which are 
transported out of the nucleus via exportins (7). B – Maximum-likelihood tree of dicer (DCR) proteins in various species reveals distinct evolutionary outgroups in the 
cestodes and trematodes. C – Maximum-likelihood tree of Argonaute genes in various species reveals loss of (piwi) piRNA processing Argonautes (AGOs), but the 
presence of a novel AGO clade in parasitic flatworms. Numbers at branch points indicate bootstrap values. 
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functional RNAi pathway (Fig. 1A; Supplementary Table 3). Consistent 
with other parasitic flatworms we found that F. hepatica possessed an 
Argonaute (AGO) that appears to belong to a parasitic flatworm specific 
AGO clade (Fig. 1C), whilst also possessing an AGO from the ‘classic’ 
clade 1 group (Skinner et al., 2014). This expansion of the AGO family in 
parasitic flatworms extends to other proteins in the RNA-induced 
silencing complex (RISC), such as the Fragile X Retardation Syndrome 
1 protein (FMR1), with four found in F. hepatica, and three in S. mansoni. 
The number of FMR1s varies between species, although most species do 
not have the three/four seen in the parasitic flatworms. For example, 
D. melanogaster possesses one, whilst mammals have an additional two 
paralogues, FXR1 and FXR2 (Wan et al., 2000). The parasitic flatworm 
FMR1s appear to group into three distinct clades with one clade 
comprised entirely of trematode-only members (Supplementary 
Figure 1M). These duplications may have occurred very early in the 
ancestry of parasitic flatworms as they display little similarity to each 
other, making it difficult to ascertain which FMR1 is the ancestral 
homologue. 
This expansion of RNAi effectors is not limited to RISC forming 
proteins as parasitic flatworms also have a Dicer-1 (DCR-1) clade that 
appears to be distinct from other species (Fig. 1B). Cestodes were known 
to have an additional DCR-1 and schistosomes were reported to have an 
additional DCR-2, a situation now mirrored in F. hepatica, suggesting 
that this duplication is common to trematodes. Although F. hepatica 
DCR-2s are smaller than FhDCR-1 (865/1154 vs 2519 amino acids), they 
still possess the conserved motifs required for RNA binding and nuclease 
activity (Supplementary Fig. 2D). 
F. hepatica, along with other trematode species appear to possess 
evolutionarily distinct ERI-1 and ERI-2 genes. F. hepatica also possesses 
two ERI-3 isoforms with both expressed in all life stages examined here 
(Supplementary Figure 3T and U); note that FhERI-3.2 is considerably 
smaller (85 vs 211 amino acids) as it is missing a conserved nuclease 
motif (HD as opposed to DEDHD), although this could be linked to 
sequence assembly error. 
With the exception of fhtsn-1.2 (maker-scaffold10x_1598_pilon-snap- 
gene-0.1), the expression of all F. hepatica putative RNAi effectors 
identified through our in silico analysis was confirmed in at least one life 
stage (Supplementary Fig. 3). However, RNA-Seq data from Cwiklinski 
et al. (2015) suggest that fhtsn-1.2 is also expressed in all life stages 
(sequence length restricted primer design). fheri-1 was not detected in 
embryonated eggs, although it was detected in unembryonated eggs 
suggesting that RNAi should be possible in even the earliest life stages of 
F. hepatica as well as all others studied here (embryonated eggs, NEJs, 
two-week-old in vitro juveniles and adults). 
3.2. Juvenile F. hepatica RNAi dynamics 
Having concluded that CS50 is currently the most effective mainte-
nance medium for in vitro culture (McCusker et al., 2016) we used it to 
investigate the effect of growth on RNAi responses in juvenile F. hepatica 
to establish the utility of RNAi as a functional genomics tool during in 
vitro development. To investigate RNAi dynamics in growing juveniles 
we focused on RNAi-mediated silencing of fhcam2 and fhσgst genes as 
both had been previously reported in liver fluke (Chemale et al., 2006; 
McCammick et al., 2016) and are likely to associate with distinct 
pathways in liver fluke with distinct expression patterns, such that their 
successful silencing would confirm the robustness of the methodology. 
However, we found that growth in CS50 significantly altered RNAi re-
sponses over the first seven days post excystment, with juveniles 
maintained in RPMI exhibiting greater transcript knockdown than those 
in CS50 (Fig. 2A; fhcam2 transcript reduction over seven days in RPMI: 
86.6%  1.1; in CS50: 66.2%  3.7; fhσgst transcript reduction in RPMI: 
78.2%  3.6; in CS50: 40.8%  7.3). This transcript knockdown over 
seven days was less than that after four days of maintenance in CS50 
(fhcam2 transcript reduction in CS50 over four days: 84.8%  2.4; over 
seven days: 66.2%  3.7 – t-test P  0.0138; fhσgst transcript reduction 
in CS50 over four days: 86.4%  0.6; over seven days: 40.8%  7.3 – 
t-test P  0.0079)), pointing to transcript recovery for both gene targets, 
between 4 and 7 days post dsRNA exposure (Fig. 2B). 
Transcript recovery could have been caused by either the degrada-
tion of residual dsRNA or growth-dependent transcript dynamics, or a 
combination of both. To test the importance of residual dsRNA in sus-
taining knockdown, CS50 (which has endogenous nuclease activity; 
Kawaguchi et al., 2009) was used to remove/degrade dsRNA (Fig. 2C) 
over 2 h following dsRNA soak, before the CS50 was washed out and 
replaced with RPMI. This induced knockdown comparable to that seen 
in juveniles maintained continually in RPMI for both genes (Fig. 2D; 
transcript reduction fhcam2 in RPMI: 86.6%  1.1; in degraded dsRNA: 
87.9%  1.1 – t-test: P  0.597; fhσgst in RPMI: 78.2%  3.6; in degraded 
dsRNA: 69.5%  2.1 – t-test: P  0.452), suggesting that reduction in 
RNAi-mediated knockdown was not linked to residual dsRNA degrada-
tion. To test the role of growth we maintained juveniles in CS20 (instead 
of CS50) following dsRNA exposure as CS20 induces a slower growth 
rate over one week (McCusker et al., 2016). Knockdown under these 
conditions lay between that seen in RPMI and CS50 for both genes 
(Fig. 2D) with transcript reduction in these worms not significantly 
different to those in RPMI or those in CS50 (fhcam2 transcript reduction 
in CS20: 71.3%  3.7; fhσgst transcript reduction in CS20: 68.3%  8.3), 
suggesting that growth rate may be a factor in F. hepatica RNAi dy-
namics. All trials showed a consistent trend whereby FhCaM2 transcript 
knockdown was more robust than that for FhσGST. 
To examine if these effects were similar in older juveniles, juveniles 
were grown for one week in CS50 prior to dsRNA exposure. Fig. 3A 
shows how, in this case, CS50 maintained juveniles exhibited less 
knockdown of fhcam2 (transcript reduction in RPMI: 96.8%  0.4; in 
CS50: 94.4%  0.6 – t-test: P  0.028), and no significant reduction for 
fhσgst (transcript reduction in RPMI: 91.8%  2.4; in CS50: 77.8%  8.3 
– t-test: P  0.16). The transcript knockdown in this trial compared 
favourably with that seen if juveniles were repeatedly soaked with 
dsRNA over a two-week period (Fig. 3A) for both fhcam2 (transcript 
reduction in repeated soaks: 95.2%  0.1) and fhσgst (transcript 
reduction in repeated soaks: 70.3%  2.4). However, when comparing 
protein knockdown between these two regimens we found that those 
treated with dsRNA just once exhibited less FhCaM2 knockdown and no 
FhσGST knockdown (Fig. 3B), whereas repeated soaking in dsRNA led to 
significant knockdown of both proteins (protein knockdown FhCaM2: 
single soak, 77%  3.5; repeated soak, 97.3%  0.4; protein knockdown 
FhσGST: single soak, 9.3%  16.3; repeated soak, 44.6%  10.5). 
When the treatment regimens were extended to run for a total of 
three weeks we found that there was little difference in the level of 
transcript knockdown (Fig. 3C) for either gene (transcript reduction 
fhcam2: single soak, 93.6%  0.2; repeated soak, 96.7%  0.3; transcript 
reduction fhσgst: single soak, 78.8%  8.4; repeated soak: 87.3%  0.9), 
suggesting that transcript recovery was not as dramatic in more devel-
oped juveniles. Therefore, to sustain gene knockdown at least one 
repeated soak per week in dsRNA appears to be required. The final 
treatment regimen over two weeks involved a dsRNA soak immediately 
post-excystment, with a ‘top-up’ soak seven days later. This induced 
significant protein knockdown (Fig. 3D) for both FhCaM2 and FhσGST 
(protein knockdown CaM2: 89.9%  1.1; σGST: 72.4%  4), comparable 
to that seen in juveniles repeatedly soaked in dsRNA (Fig. 3A and B). 
Our liver fluke maintenance platform allows us to maintain juveniles 
for many months in vitro, and to ensure that RNAi-mediated studies 
could be carried out in these worms we grew juveniles in CS50 for five 
months before repeatedly soaking the worms in dsRNA over a two-week 
period. This method resulted in both transcript and protein knockdown 
of FhσGST (Fig. 4A and B), but only transcript knockdown of FhCaM2 
(transcript knockdown: FhCaM2, 94.2%  2.9; FhσGST, 93.9%  1.4; 
protein knockdown: FhCaM2, 0% (upregulation 149%  48); FhσGST, 
88%  3). This is the greatest transcript knockdown, and consequently 
protein knockdown, of FhσGST seen in any of our treatment regimens. 
This suggests that transcript abundance may play a role in RNAi 
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Fig. 2. Growth of juvenile Fasciola hepatica over the first week following excystment alters RNA interference (RNAi) dynamics. A – Percentage expression of 
F. hepatica sigma glutathione transferase (fhσgst)/F. hepatica calmodulin 2 (fhcam2) transcript relative to F. hepatica glyceraldehyde phosphate dehydrogenase 
(fhgapdh) after double stranded RNA (dsRNA) exposure and six days maintenance in 50% chicken serum (CS50) or RPMI shows reduced knockdown in juveniles 
maintained in CS50. B – Percentage expression of fhσgst/fhcam2 transcript relative to fhgapdh after dsRNA exposure and three days maintenance in CS50 shows robust 
knockdown for both genes. C – Agarose gel electrophoresis image showing (i) 100 ng/μl of dsRNA in RPMI, (ii) 100 bp ladder (iii) 100 ng/μl dsRNA in RPMI at 37 C 
for 2 h and, (iv) 100 ng/μl dsRNA in CS50 at 37 C for 2 h, showing dsRNA removal/degradation in CS50. D – Percentage expression of fhσgst/fhcam2 transcript 
relative to fhgapdh after dsRNA exposure followed by either dsRNA removal or six days maintenance in 20% chicken serum (CS20) showing how dsRNA removal has 
little impact on knockdown. Treatment timelines (in days) above graphs show media juveniles were maintained in; y axis dotted line at 100% represents mean 
transcript expression in untreated juveniles; colours of gene in y axis correspond to gene expression on graphs. Unpaired t-tests used to test for significant differences 
where *, P < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web 
version of this article.) 
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Fig. 3. The impact of single and repeated dsRNA exposures on transcript and protein knockdown in juvenile Fasciola hepatica during in vitro growth. A – 
Percentage expression of F. hepatica sigma glutathione transferase (fhσgst)/F. hepatica calmodulin 2 (fhcam2) transcript relative to F. hepatica glyceraldehyde 
phosphate dehydrogenase (fhgapdh) following distinct dsRNA treatment protocols shows that when grown for one week prior to dsRNA exposure, the maintenance 
media post exposure does not alter the knockdown response. B – Over a two-week in vitro maintenance timecourse, the knockdown of fhσgst/fhcam2 proteins relative 
to controls in juvenile fluke was most efficient following repeated exposures to dsRNA, with single dsRNA exposures being less effective. C - Over a three-week in vitro 
maintenance timecourse, the knockdown of fhσgst/fhcam2 transcripts relative to controls in juvenile fluke was similar following single or repeated exposure to 
dsRNA. D – Over a three-week in vitro maintenance timecourse, the knockdown of FhσGST/FhCaM2 proteins relative to controls in juvenile fluke was robust 
following a single exposure to dsRNA after one week of growth. Treatment timelines (in days) above graphs show media that juveniles were maintained in; y axis 
dotted line at 100% represents mean transcript/protein expression in untreated juveniles; colours of gene/protein in y axis correspond to gene/protein expression on 
graphs. Unpaired t tests used to test for transcript knockdown and ANOVAs for protein knockdown *, P < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. (For 
interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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susceptibility/dynamics as fhσgst expression increases over time in 
worms grown in vitro, whereas fhcam2 decreases (Fig. 4C). 
Together, these data highlight an increased robustness of RNAi- 
mediated gene silencing in F. hepatica juveniles at different stages of 
development using a repeated soaking methodology. Our improved 
methodology of repeated dsRNA soaks (24 h/soak) over an extended 
period has now allowed us to efficiently silence genes in both stem cells 
(fhmap3k1) and muscle tissue (fhparamyo) of juvenile F. hepatica (Sup-
plementary Fig. 4). 
4. Discussion 
Due to the threat that F. hepatica poses to global food security and to 
human health, it is critical that novel targets for control are identified. 
RNAi could aid in the identification and validation of these targets and 
we have shown here that all life stages of F. hepatica express the 
necessary molecular machinery to support RNAi. Interestingly, it ap-
pears that liver fluke, along with other parasitic flatworms, have un-
dergone expansion of the RNAi effector machinery. Our results 
strengthen the idea that the piwi-clade AGOs have been lost in the 
parasitic flatworms, only to be replaced by a parasitic flatworm specific 
clade (Skinner et al., 2014), with an as yet unknown function. It is 
possible that this novel pathway acts on parasitic flatworm transposons 
(DeMarco et al., 2004; Jacinto et al., 2011; Koziol et al., 2015), as the 
piRNA, endo si-RNAs and clade I AGOs do in germ line and somatic cells 
in other eukaryotes (Vagin et al., 2006; Houwing et al., 2007; Chung 
et al., 2008; Ghildiyal et al., 2008; Kawamura et al., 2008). Given the 
difference in the number of repeat sequences between the UK and 
Oregon F. hepatica genomes (30.6% and 55.3%) (McNulty et al., 2017) it 
may be that the regulation of transposable elements does not occur in 
the parasitic flatworms, hence the absence of PIWI AGOs in F. hepatica. 
Further evidence to support the idea that these parasitic flatworm 
AGOs have replaced the Piwi proteins comes from Schistosoma sp. as 
ago2 is highly expressed in S. mansoni (Cogswell et al., 2011) and has 
ubiquitous expression in S. japonicum where it is thought to be expressed 
in both germline and somatic cells (Cai et al., 2012). Given that all of the 
F. hepatica AGOs, including those specific to parasitic flatworms, are 
expressed in all life stages, it is possible that they exhibit ubiquitous 
expression, as reported in schistosomes. Our analysis shows that other 
RNAi effectors have undergone expansion in the parasitic flatworms, 
such as FMR1s which may form part of the RISC. These predicted 
FMR-like proteins are strikingly divergent from orthologues in other 
eukaryotes, forming two distinct groups, with F. hepatica possessing four 
genes in total. All four fhfmr-like genes were expressed in all F. hepatica 
life stages, suggesting involvement in baseline processes consistent 
throughout the life cycle; localisation studies would help inform any 
associated tissue specificities. 
The expansion of the RNAi effectors in the parasitic flatworms sug-
gests that the RISC associated with piRNAs in other eukaryotes has been 
replaced by a novel RISC in the parasitic flatworms. As piRNAs have not 
been observed in the parasitic flatworms it is possible that they possess a 
different, and unique, subset of noncoding RNAs. Further evidence for a 
separate noncoding RNA pathway is provided by the expansion of DCR 
and ERI clades in parasitic flatworms. Both cestodes and trematodes 
possess a novel dcr gene as well as a distinct eri-2 gene. Flukes also 
appear to express an additional eri-1 that seems to have been lost in 
cestodes. This additional DCR could act on ncRNA precursors prior to 
RISC incorporation in a similar way to how DCR processes endo-siRNAs 
found in both germ and somatic cells of mammals and flies (Czech et al., 
2008; Tam et al., 2008; Ghildiyal et al., 2008; Song et al., 2011), whilst 
novel ERIs may act as inhibitors of this pathway. 
As our in silico analysis suggested that all life stages of the liver fluke 
have a functioning RNAi pathway we wanted to further explore the 
utility of RNAi in different F. hepatica developmental life stages. As our 
culture platform developments (McCusker et al., 2016) include changes 
to the base medium used to maintain juveniles during in vitro trials we 
wanted to establish if this affected RNAi efficiency. We found that in 
vitro growth in CS50 results in transcript recovery over the first seven 
days post excystment, but this has less of an effect once juveniles are 
more than seven days old. Transcript recovery has not been previously 
noted in RNA dynamics studies in F. hepatica (Dell’Oca et al., 2014; 
McVeigh et al., 2014), likely due to the fact that the juveniles used in 
those studies had not been maintained in growth-promoting media. This 
observation of transcript recovery in F. hepatica differs from that seen in 
Schistosoma sp. where in vitro RNAi is persistent for many weeks (Cor-
renti et al., 2005; Krautz-Peterson et al., 2010), highlighting both the 
potential challenges in optimizing RNAi under conditions where growth 
and development are not occurring as well as the differences in Fasciola 
and Schistosoma, two species often compared during RNAi phenotypic 
readouts. Changes in transcriptional activity in the first week 
post-excystment may contribute to the transcript recovery observed and 
work in mammalian cell lines has highlighted that such gene expression 
dynamics may associate with diminished RNAi susceptibility (Larsson 
et al., 2010). This period of rapid gene expression change following 
excystment correlates with the increased metabolic activity that occurs 
as NEJs transition from a sedentary life stage to an actively developing, 
migrating and feeding life stage. 
The observation that the ability of transient dsRNA exposure to 
trigger RNAi in juvenile fluke was not altered when CS50 was used to 
reduce the amount of residual dsRNA in the bathing medium post dsRNA 
treatment, indicates that the initial dsRNA exposure is the key trigger for 
gene silencing. Therefore, subsequent gene silencing dynamics are a 
result of the continued processing and internal transport of RNAi trig-
gers acquired by the fluke during the transient dsRNA exposure phase. 
Also, changes in the efficiency of gene knockdown in fluke maintained in 
different media (RPMI, CS20 or CS50) supports our proposed association 
between transcript recovery and fluke growth over the first week post- 
excystment. 
It was also noteworthy that the expression of many RNAi effectors, 
such fhago1 and fhago2, increased after one week of growth in CS50, 
compared to juveniles maintained in RPMI (Fig. 4D). fhago2, which 
doubled in expression, is known to be crucial for siRNA-directed gene 
silencing in D. melanogaster (Okamura et al., 2004), suggesting that it is 
crucial in exogenous dsRNA/siRNA gene silencing. Given that juveniles 
grown in CS50 for one week prior to dsRNA exposure did not exhibit 
differences in RNAi efficiency between different media, it appears that 
RNAi effector expression levels have little impact on RNAi efficiency in 
vitro. Our results suggest that in vitro fluke growth is the key factor that 
alters RNAi dynamics in early stage juveniles. 
From our experiments we concluded that repeatedly soaking juve-
niles in dsRNA is necessary to ensure sustained target transcript 
knockdown. Repeated dsRNA exposure facilitated the most efficient 
protein knockdown, most likely because this reduced the opportunity for 
the recovery of target expression. However, as noted in previous studies, 
it can take over a week to elicit a reasonable level of protein knockdown 
for some genes in F. hepatica (McVeigh et al., 2014; McCammick et al., 
2016). Therefore, we recommend that to achieve RNAi in growing 
F. hepatica juveniles repeated dsRNA exposures are necessary to ensure 
the robust knockdown of transcript and protein across periods in excess 
of a week. We confirmed this by testing repeated 24 h dsRNA soaks over 
the course of a month for two genes expressed in stem cells (fhmap3k1) 
and muscle tissue (fhparamyo), with extensive transcript knockdown in 
both cases, confirming the robustness of our functional genomics plat-
form in this crucial life stage. 
We also observed differences in the level of knockdown (both tran-
script and protein) between target genes as fhcam2 exhibited consis-
tently higher knockdown than fhσgst in the early stage juveniles. 
However, in juveniles grown for five months prior to RNAi trials we 
found that FhσGST protein was silenced more effectively than FhCaM2. 
These differences appear to correlate with the relative abundance of 
each transcript as in the early stage juveniles fhcam2 is more abundant 
than fhσgst, whereas in the later stage juveniles (five months) the reverse 
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is true. Work in mammalian cell lines has observed correlations between 
transcript abundance and RNAi susceptibility with higher expressed 
transcripts being more amenable to RNAi mediated knockdown (Hong 
et al., 2014). 
We have also carried out the first successful RNAi in adult F. hepatica 
using two different methodologies (Supplementary File 2). Both nano-
injection and soaking of adults appeared to elicit knockdown of FhCatL, 
FhσGST and FhCaM2 (Supplementary Figs. 5A and B). However, 
although these approaches appeared to elicit robust transcript knock-
down over 48 h there was no reduction in protein levels observed 
(Supplementary Fig. 5C). This lack of protein knockdown may relate to 
transcript turnover rates being affected by deteriorating health when 
worms are removed from the host. This suggests that the chief barrier to 
a robust RNAi platform in adult F. hepatica is the lack of a reliable in vitro 
maintenance system. 
The results presented here highlight the fluid dynamics of RNAi in a 
growing parasitic flatworm for the first time. As such we recommend the 
use of a ‘repeated dsRNA soaking’ methodology to ensure robust RNAi in 
F. hepatica juveniles and facilitate phenotypic studies. The confirmation 
of a functional RNAi pathway in all life stages of the liver fluke means 
that this functional genomics tool can be utilized to ascertain gene 
function across all key life stages although a study by Beesley et al. 
(2016) demonstrated the genetic diversity of wild populations of 
F. hepatica within the UK, another factor that could have implications for 
RNAi susceptibility. Here we have demonstrated a robust platform for 
gene silencing in the highly pathogenic juvenile stage liver fluke which 
will facilitate the exploitation of the new genomic/transcriptomic 
datasets to advance studies on liver fluke biology. 
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